The proposed bill amends section 28-405 of the Revised Statutes Cumulative Supplement, 2024, to classify tianeptine as a controlled substance under the Uniform Controlled Substances Act, reflecting concerns about its potential misuse and associated health risks. The bill aims to enhance public health and safety by regulating the use and distribution of tianeptine, thereby preventing unauthorized access. It also includes a comprehensive update to the legal framework governing controlled substances in Nebraska, which involves the repeal of the original section and the introduction of specific definitions and classifications for various synthetic compounds and their derivatives.

Additionally, the bill outlines new regulations for the classification of controlled substances, including various narcotics, stimulants, depressants, and hallucinogens, with a focus on substances that affect the central nervous system. It specifies that any material containing ephedrine is generally prohibited unless it meets certain exceptions, such as being stored behind a counter and sold to customers aged eighteen or older. The bill also introduces new regulations for Schedule V substances and includes provisions for labeling and marketing to prevent abuse. Overall, the amendments aim to streamline legal language and enhance regulatory oversight to effectively address issues related to drug abuse and public health.

Statutes affected:
Introduced: 28-405